# Xilio Therapeutics, Inc.: Form 8-K, filed Mar 12, 2026

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2026-03-12
- Accepted by EDGAR: Mar 12, 2026, 08:34 ET
- Period: 2026-03-12
- Accession: 0001193125-26-103150
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000119312526103150/xlo-20260312.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000119312526103150/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000119312526103150/xlo-20260312.htm

Filed Mar 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-103150. Last ingested by Listed: Nov 15, 2026, 04:19 ET. No prices; not investment advice.
